News

Walmart steps up Prime Day competition

BY Dan Berthiaume
Walmart was offering its own July online savings event before Amazon Prime Day was officially announced, and now the discount giant is sweetening its deal.
 
Walmart is offering all customers free shipping with no minimum purchase on its e-commerce site from Monday, July 11 – Friday, July 15. This builds on a previously announced online promotion that offers a free 30-day trial of the retailer’s ShippingPass program, which provides consumers unlimited, two-day free shipping for a year.
 
The free ShippingPass trial offer is still in place, but this new offer takes things a step further. Notably, Amazon Prime Day is only open to members of the Amazon Prime unlimited delivery service, which costs $99 per year. Amazon is offering its own free 30-day trial, but Walmart can now reach consumers who may be wary of signing up for an online service.
 
In a press release, Walmart did not mention Amazon or Prime Day by name, but made it clear the timing of its latest online discount offer is not coincidental.
 
“At Walmart, we believe saving money every day is better than just one, and that all customers should save, not only some,” said the release. “To help ALL customers save even more, Walmart.com just announced free shipping with no minimum purchase, starting Monday, July 11 through Friday, July 15.”
 
Furthermore, Walmart is offering several new online rollback deals on big-ticket items such as HDTVs, laptops, iPhones and Xbox game consoles.
 
In addition to offering its own July online sales event, Walmart has also treaded on Amazon’s turf by providing online grocery delivery and free cloud hosting services, as well as by testing delivery drones. In 2015, Walmart competed with the hugely successful Prime Day event by lowering the minimum order for free shipping from $50 to $35 and lowering online prices for thousands of items.
 
Walmart also heavily counterprogrammed against Prime Day in 2015, and Amazon still had a rousing success with the event. It is unlikely that Walmart or any other retailer will have any serious impact on Prime Day performance this year, regardless of what they offer. But that is not the point. With this undertaking, Walmart is putting Amazon and consumers on notice that it considers the world’s most successful e-commerce retailer as a legitimate target for stealing online market share.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Mylan launches generic Temodar capsules

BY David Salazar
PITTSBURGH — Mylan on Monday launched its generic of Temodar (temozolomide) capsules. The drug is indicated to treat newly diagnosed tumors called glioblastoma multiforme alongside radiotherapy and then as a maintenance treatment. 
 
Mylan’s temozolomide tablets will be available in 5-, 20-, 100-, 140-, 180- and 250-mg dosage strengths. The drug had U.S. sales of about $176.5 million for the 12 months ended May 31, according to IMS Health data. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

FDA approves wearable delivery system for Amgen’s Repatha

BY DSN STAFF
SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug delivery device for Amgen’s Repatha (evolocumab), the company announced Monday. The Pushtronex system is an on-body infusor with a pre-filled cartridge with a 420-mg monthly dose of the cholesterol-lowering drug, one of two new drugs in a class of PCSK9 inhibitors. 
 
“The Pushtronex system exemplifies Amgen's continued innovation and commitment to patients,” Amgen’s EVP research and development Dr. Sean Harper said. “Repatha is the only PCSK9 inhibitor with an approved monthly dose, and now the only one with a monthly single-dose administration. The FDA approval of the Pushtronex system offers another delivery option to patients who need the additional LDL cholesterol lowering that Repatha can provide."
 
Amgen developed the Pushtronex system in collaboration with injectable drug delivery innovation company West Pharmaceutical Services, basing it on West’s SmartDose technology platform. The device allows patients to perform such moderate physical activities as walking, reaching or bending as the drug is being delivered subcutaneously. Drug Store News wrote about SmartDose in April as part of its look at the changing role of wearable technology.  
 
“West is very pleased that Amgen has selected the SmartDose technology platform for the new monthly single dose administration option of Repatha,” West president and CEO Eric Green said. "The combination of Amgen's innovative treatment with West's patient-focused technology platform is an example of how West closely collaborates with our pharmaceutical and biotechnology partners to deliver advanced, integrated solutions for drug delivery and containment."
 
Amgen said it expects for the Pushtronex system to be available in early August. Repatha is also available for delivery every two weeks via a SureClick autoinjector. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?